Preparing for PrEP.
Eur J Contracept Reprod Health Care
; 17(6): 482-6, 2012 Dec.
Article
em En
| MEDLINE
| ID: mdl-23113873
ABSTRACT
Recent studies have shown that in selected conditions antiretroviral drugs can be used to protect HIV seronegative persons from becoming infected, when exposed to the risk of sexual HIV transmission. This concept of 'pre-exposure prophylaxis' or 'PrEP' has raised many questions that concern cost, safety and ethical issues. In this article, different aspects of PrEP are analysed with a view to trying to answer the question whether today's society is already prepared to accept PrEP as one of the tools to prevent transmission of HIV by high-risk sexual contacts.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pré-Medicação
/
Infecções por HIV
/
Fármacos Anti-HIV
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Eur J Contracept Reprod Health Care
Assunto da revista:
MEDICINA REPRODUTIVA
/
SERVICOS DE PLANEJAMENTO FAMILIAR
Ano de publicação:
2012
Tipo de documento:
Article
País de afiliação:
Bélgica